Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Neuromodulation Market Growth in 2025?

There has been a rapid expansion in the size of the neuromodulation market in the preceding years. The market, valued at $6.96 billion in 2024, is predicted to escalate to $7.68 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.3%. The historic period’s growth can be ascribed to an increased prevalence of chronic conditions, corroborating clinical research, patient preference for non-invasive treatment options, government-led initiatives and financial backing, widening usage indications, and strategic collaborations and partnerships.

What Is the Forecast for the Neuromodulation Market Size Through 2029?

The neuromodulation market is predicted to experience significant expansion in the coming years, with the market projected to reach a value of “$11.79 billion by 2029, reflecting a compound annual growth rate (CAGR) of 11.3%. The predicted growth in the forecast period is due to factors such as the miniaturization of devices, a growing emphasis on neurological disorders in the elderly, broadened uses in psychiatry, patient-centric methods, and enhanced global healthcare access. Key trends expected to shape the sector during the forecast period are the incorporation of artificial intelligence (AI), progress in technology, the introduction of non-invasive neuromodulation techniques, the development of closed-loop neuromodulation systems, widening of indications, and the emergence of wireless and wearable neuromodulation devices.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10142&type=smp

What are the Key Market Players in Neuromodulation Market and How They’re Evolving?

Major companies operating in the neuromodulation market include Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, Neuropace Inc., LivaNova PLC, Neurosigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, ReShape Lifesciences Inc., Inspire Medical Systems Inc., Bioventus LLC, Saluda Medical Pty Ltd, Otolith Labs Inc., Machine Medicine Inc., Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuronoff ApS, Neuros Medical Inc., Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., Magic Leap Inc., Omron Corporation

What Are the Primary Growth Drivers in the Neuromodulation Market?

The intensifying occurrence of neurological disorders is anticipated to drive the neuromodulation market’s expansion. Neurological disorders are fundamentally characterized as issues that influence the brain, along with nerves existing throughout the human body and the spinal cord. Neuromodulation offers the potential to treat and modify a variety of neurological disorders and diseases, including Parkinson’s and Alzheimer’s diseases. For example, as observed by the European Brain Council in April 2022, a coordinating international health organization based in Belgium, there were more than 600 neurological diseases, and almost 300 psychiatric conditions recorded. Globally, 50 million people were living with Alzheimer’s and other forms of dementia. Epilepsy, a common disorder, affected 65 million people worldwide. In Europe, dementia was found in 10.5 million individuals, projected to rise to 18.7 million by 2050. Therefore, the increasing occurrence of neurological disorders is fuelling the expansion of the neuromodulation market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10142&type=smp

What Are the Leading Segments in the Global Neuromodulation Industry?

The neuromodulation market covered in this report is segmented –

1) By Technology: Internal Neuromodulation, External Neuromodulation (Non-invasive)

2) By Biomaterial: Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial

3) By Application: Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications

4) By End-User: Hospitals, Clinics, Home Healthcare

Subsegments:

1) By Internal Neuromodulation: Implantable Devices, Intrathecal Drug Delivery Systems

2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)

What Are the Key Market Trends in the Neuromodulation Industry?

Rapid advancements in technology are becoming a prominent trend within the neuromodulation market. To consolidate their market stance, several key companies are investing in the development of innovative technical solutions. Take for example GrayMatters Health, an entity hailing from Israel that specializes in digital self-neuromodulation therapies. In January 2024, they unveiled Prism, an FDA-approved self-neuromodulation therapy for PTSD. This ground-breaking device, which blends an EEG cap with software, empowers patients to regulate their emotional reactions through neurofeedback. The inventive technology is aimed to enhance conventional psychotherapy and pharmacotherapy by providing patients with active symptom management tools. Furthermore, Abbott Laboratories, a US medical devices and healthcare firm, launched in December 2022 the Eterna spinal cord stimulation (SCS) system, which is the smallest implantable and rechargeable spinal cord stimulator on the market. The Eterna SCS uses Abbott’s unique low-dose BurstDR stimulation that holds the highest level of clinical proof (1A evidence). It has proven to augment pain relief by an additional 23% over regular waveform technology methods.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

What Is the Regional Outlook for the Neuromodulation Market?

North America was the largest region in the neuromodulation market in 2024. The regions covered in the neuromodulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10142

This Report Delivers Insight On:

1. How big is the neuromodulation market, and how is it changing globally?

2. Who are the major companies in the neuromodulation market, and how are they performing?

3. What are the key opportunities and risks in the neuromodulation market right now?

4. Which products or customer segments are growing the most in the neuromodulation market?

5. What factors are helping or slowing down the growth of the neuromodulation market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model